Menu Back to Marketing-Pharmaceuticals-2013-Workshop-for-Regulatory-Legal-Communications-Professionals-and-Promotional-Review-Teams

Program Committee

  • Thomas W. Abrams, MBA, RPh
    Thomas W. Abrams, MBA, RPh Director, Office of Prescription Drug Promotion, OMP, CDER
    FDA, United States
  • Glenn N. Byrd, MBA, RAC
    Glenn N. Byrd, MBA, RAC Senior Director, Specialty Care Promotional Regulatory Affairs
    Astrazeneca, United States
  • Mark  Gaydos
    Mark Gaydos VP and Head, US Specialty Care 2, North America and Global Regulatory Affairs  
    Sanofi US, United States
  • John T. Murray
    John T. Murray President
    Grayscale Compliance LLC, United States
  • Wayne L. Pines
    Wayne L. Pines President, Regulatory Services and Healthcare
    APCO Worldwide Inc., United States
  • Lucy  Rose, MBA
    Lucy Rose, MBA President
    Lucy Rose and Associates, LLC, United States
  • Kristina  Vlaovic, MPH
    Kristina Vlaovic, MPH Vice President, Regulatory, Safety and Pharmacovigilance
    HALOZYME Inc., United States
Load More